Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

All Cosmos Bio-Tech Holding Corp. (4148) Financial Statements

All Cosmos Bio-Tech Holding Corp. Financial Overview

All Cosmos Bio-Tech Holding Corp.'s market cap is currently NT$1.96B. The company's EPS TTM is NT$2.76; its P/E ratio is 10.66; and it has a dividend yield of 3.40%. All Cosmos Bio-Tech Holding Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 2.95BNT$ 2.46BNT$ 2.83BNT$ 3.70BNT$ 2.20B
Gross ProfitNT$ 829.47MNT$ 668.59MNT$ 587.98MNT$ 1.14BNT$ 594.37M
Operating IncomeNT$ 296.59MNT$ 155.88MNT$ 189.90MNT$ 645.50MNT$ 265.62M
EBITDANT$ 362.56MNT$ 312.83MNT$ 310.76MNT$ 699.84MNT$ 373.03M
Net IncomeNT$ 153.00MNT$ 128.59MNT$ 139.36MNT$ 368.20MNT$ 198.13M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 1.44BNT$ 1.25BNT$ 1.66BNT$ 1.47BNT$ 930.13M
Total AssetsNT$ 4.22BNT$ 3.67BNT$ 3.67BNT$ 4.11BNT$ 2.97B
Total DebtNT$ 381.29MNT$ 261.61MNT$ 543.09MNT$ 942.46MNT$ 311.31M
Net DebtNT$ -843.34MNT$ -672.32MNT$ -915.77MNT$ -399.05MNT$ -429.13M
Total LiabilitiesNT$ 779.83MNT$ 540.27MNT$ 859.54MNT$ 1.25BNT$ 591.28M
Stockholders' EquityNT$ 2.74BNT$ 2.52BNT$ 2.25BNT$ 2.37BNT$ 1.99B
Cash Flow
Free Cash FlowNT$ 209.08MNT$ -88.06MNT$ 795.82MNT$ -17.02MNT$ -171.49M
Operating Cash FlowNT$ 251.93MNT$ 54.19MNT$ 959.24MNT$ 43.84MNT$ -67.64M
Investing Cash FlowNT$ -277.80MNT$ -228.46MNT$ -202.98MNT$ -4.67MNT$ -108.17M
Financing Cash FlowNT$ 82.94MNT$ -428.49MNT$ -549.88MNT$ 490.39MNT$ 196.10M

Currency in TWD

All Cosmos Bio-Tech Holding Corp. Earnings and Revenue History

01.5B3B4.5B0 %5 %10 %15 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

All Cosmos Bio-Tech Holding Corp. Liabilities to Assets

01.5B3B4.5B0 %12 %24 %36 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

All Cosmos Bio-Tech Holding Corp. Cash Flow

-1B-500M0500M1B1.5B201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

All Cosmos Bio-Tech Holding Corp. Forecast EPS vs Actual EPS

-0.200.30.50.811.31.5Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >